Teva, Impax To Pull Generic Wellbutrin After FDA Finding
The U.S. Food and Drug Administration said Wednesday that Teva Pharmaceuticals USA Inc. and Impax Laboratories Inc. would remove a generic version of the antidepressant Wellbutrin XL from the market following...To view the full article, register now.
Already a subscriber? Click here to view full article